Frontiers in Immunology (May 2022)

Inhibition of Heme Oxygenase-1 by Zinc Protoporphyrin IX Improves Adverse Pregnancy Outcomes in Malaria During Early Gestation

  • Yusmaris Cariaco,
  • Marcos Paulo Oliveira Almeida,
  • Ester Cristina Borges Araujo,
  • Marisol Patricia Pallete Briceño,
  • Andrea Tatiana Durán-Rodriguez,
  • Rodrigo Rodrigues Franco,
  • Foued Salmen Espindola,
  • Neide Maria Silva

DOI
https://doi.org/10.3389/fimmu.2022.879158
Journal volume & issue
Vol. 13

Abstract

Read online

The enzyme heme oxygenase-1 (HO-1) has cytoprotective effects by catalyzing the degradation of heme to produce carbon monoxide, iron and biliverdin. Furthermore, HO-1 activity has been associated with successful pregnancy. On the other hand, in the context of certain inflammatory conditions, HO-1 can induce iron overload and cell death. To investigate the role of HO-1 in gestational malaria, pregnant BALB/c mice were infected with Plasmodium berghei ANKA in early, mid and late gestation. We found that malaria affected the pregnancy outcome in the three periods evaluated. However, only poor pregnancy outcomes in early pregnancy were related to HO-1 upregulation, iron overload, lipid peroxidation and necrosis of the decidua, which were prevented by HO-1 inhibition. In conclusion, HO-1 expression must be finely tuned in gestational malaria to avoid the deleterious effect of increased enzyme activity.

Keywords